抗DNA结合与RNA结合蛋白的新型IgG和IgA自身抗体可区分系统性红斑狼疮与健康及非狼疮自身免疫,抗LIN28A能否提高诊断精准度
研究基于KoRectly EXpressed技术微阵列,在两个独立队列中筛查1609种蛋白的IgG和IgA自身抗体,纳入系统性红斑狼疮、原发性舍格伦病、系统性硬化症患者及健康对照。鉴定并验证了5种IgG和4种IgA自身抗体对系统性红斑狼疮具有高特异性(0.91-0.94),抗LIN28A的IgG和IgA在验证队列14个月随访中有波动,其指标优于抗双链DNA等传统标志物。
要点
- 鉴定并验证5种IgG和4种IgA自身抗体对系统性红斑狼疮具有高特异性(0.91-0.94)。
- IgG和IgA抗LIN28A指标优于抗双链DNA等传统自身抗体标志物。
- 显著IgA血清反应性提示黏膜组织在系统性红斑狼疮自身免疫中可能起重要作用,需进一步研究。
核心结论
- 本研究验证的新型自身抗体可能提升系统性红斑狼疮的诊断和分子特征描述。
- 显著的IgA血清反应性提示黏膜组织在系统性红斑狼疮自身免疫中可能起重要作用,需进一步研究。
研究设计与样本
- 基于KoRectly EXpressed技术的微阵列(i-Ome Discovery;Sengenics)筛查循环IgG和IgA自身抗体,针对1609种蛋白。
- 发现队列(NTC02890121)纳入系统性红斑狼疮199例、原发性舍格伦病115例、系统性硬化症115例、健康对照111例。
- 验证队列(NCT02890134)纳入系统性红斑狼疮30例、原发性舍格伦病31例、系统性硬化症24例、健康对照84例。
主要发现
- 鉴定并验证5种IgG自身抗体(抗LIN28A、抗HNRNPA2B1、抗HMG20B、抗HMGB2、抗TFCP2)和4种IgA自身抗体(抗LIN28A、抗HMG20B、抗SUB1、抗TFCP2)对系统性红斑狼疮具有高特异性(0.91-0.94)。
- 在系统性红斑狼疮与对照组的差异丰度自身抗体分析中,上述自身抗体阳性率为0.22-0.69。
- 在验证队列中新诊断系统性红斑狼疮患者中,IgG和IgA抗LIN28A水平在14个月随访期间有变化,其指标优于抗双链DNA等传统自身抗体标志物。
- 基于自身抗体阳性(发现队列中水平高于健康对照中位数加2个四分位距)对系统性红斑狼疮患者聚类,发现1个亚组对多种抗原血清反应阳性、3个亚组反应性各异、1个亚组无反应性。
- 通路分析显示差异丰度自身抗体靶点涉及DNA结合、RNA结合及转录功能。
局限性
- 原文结论指出显著的IgA血清反应性提示黏膜组织在系统性红斑狼疮自身免疫中可能起重要作用,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In response to the urgent unmet needs of heterogeneity, unpredictability, and diagnostic delay in systemic lupus erythematosus (SLE), we aimed to identify and validate new immunoglobulin (Ig)G and IgA autoantibody specificities. METHODS: Using a KoRectly EXpressed technology-based microarrays (i-Ome Discovery; Sengenics), we screened for circulating IgG and IgA autoantibodies against 1609 proteins in 2 independent cohorts (discovery: NTC02890121; validation: NCT02890134) comprising patients with SLE (n = 199 and n = 30), primary Sjögren's disease (n = 115 and n = 31), and systemic sclerosis (n = 115 and n = 24), and healthy controls (HCs; n = 111 and n = 84), respectively. RESULTS: We identified and validated 5 IgG (anti-Lin-28 homolog A [LIN28A], anti-HNRNPA2B1, anti-HMG20B, anti-HMGB2, and anti-alpha-globin transcription factor CP2 [TFCP2]) and 4 IgA (anti-LIN28A, anti-HMG20B, anti-SUB1, and anti-TFCP2) autoantibodies that demonstrated high specificity for SLE (0.91-0.94), along with consistent and robust positivity (0.22-0.69) in differentially abundant autoantibody (daAAb) analysis between SLE and comparator groups. IgG and IgA anti-LIN28A levels varied over a 14-month follow-up in the validation cohort of newly diagnosed patients with SLE and exhibited metrics that outperformed those of traditional autoantibody markers such as anti-double-stranded DNA. Clustering of patients with SLE based on autoantibody positivity (levels above the HC median plus 2 IQRs in the discovery cohort) status revealed 1 subgroup demonstrating seroreactivity against multiple antigens, 3 exhibiting varying reactivity, and 1 showing no reactivity. In pathway analysis, daAAb targets pointed to DNA-binding and RNA-binding and transcription functions. CONCLUSIONS: Novel autoantibodies validated in this study may enhance diagnostics and molecular characterisation in SLE. The prominent IgA seroreactivity implicates important roles of mucosal tissues in SLE autoimmunity, warranting further investigation.
引用
- Parodis I, Lagutkin D, Lindblom J, et al. New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics? Ann Rheum Dis. 2025. PMID: 40374430. doi:10.1016/j.ard.2025.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。